ArticleClinical ophthalmology (Auckland, N.Z.)2016

A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension.

Annemie Stevens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.